63
Participants
Start Date
June 7, 2016
Primary Completion Date
February 15, 2017
Study Completion Date
March 15, 2017
Pegfilgrastim
A fixed dose of 6.0 mg pegteograstim was administered subcutaneously on day 2 of each chemotherapy cycle (between 22 and 26 hours after the completion of chemotherapy).
Doxorubicin/Cyclophosphamide(AC) treatment
"doxorubicin 60mg/m2 IV every 2 weeks cyclophosphamide 600mg/m2 IV every 2 weeks~Four cycles of dose dense AC treatment will be given every 2 weeks."
Division of Medical Oncology, Severance Breast Cancer Clinic, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul
Yonsei University
OTHER